Union Health Ministry Proposes Amendments to Drugs Rules, 1945 to Strengthen Regulatory Oversight of Schedule H, H1 and X Drugs

1. At a Glance

• Union Health Ministry has proposed amending the Drugs Rules, 1945 (draft gazette notification dated 8 September 2026) to tighten control over Schedule H, H1 and X drugs [1].
• Core aim: curb unauthorised access to and sale of prescription-only and narcotic/psychotropic drugs, and improve pharmaceutical supply-chain monitoring [1].
• Proposal includes CCTV surveillance at medical stores as a transparency/accountability safeguard [1].
• High-yield for Prelims (Schedule classifications, enabling Act) and Mains GS-II (health governance) / GS-III (pharma regulation, drug resistance).

2. Why in the News

• Draft gazette notification issued 8 September 2026 proposing amendments to the Drugs Rules, 1945, specifically targeting Schedule H, H1 and X drugs [1].
• Trigger: concerns over unauthorised/over-the-counter sale of restricted drugs without valid prescriptions, and gaps in retail-level monitoring [1].

3. Background & Evolution

• Drugs Rules, 1945 framed under the Drugs and Cosmetics Act, 1940 — the parent statute regulating import, manufacture, and sale of drugs and cosmetics in India [2].
• Schedule H1 was inserted via Gazette Notification GSR 588(E), dated 30 August 2013, effective 1 March 2014, listing 46 drugs including third/fourth-generation antibiotics, anti-TB drugs, and certain habit-forming drugs, to curb antimicrobial resistance through unchecked OTC antibiotic sale [3].
• 2015 amendment: barred advertisement of drugs under Schedule H, H1 and X without prior sanction of the Central Government [4].
• July 2026 amendment: formulations with more than 12% v/v ethyl alcohol in quantities exceeding 30 mL removed from Schedule K exemption and shifted to Schedule H1, requiring RMP prescription and stricter record-keeping [4].
• Present (September 2026) proposal is the latest step in this continuing tightening trajectory [1].

4. Core Static Facts

• Enabling Act: Drugs and Cosmetics Act, 1940; Rules: Drugs Rules, 1945 [2].
• Implementing Ministry: Union Ministry of Health and Family Welfare (MoHFW); regulator: CDSCO (Central Drugs Standard Control Organisation).
• Schedule H: prescription drugs — sold by retail only on a Registered Medical Practitioner's (RMP) prescription [3].
• Schedule H1: 46 specified drugs (antibiotics, anti-TB, habit-forming) requiring separate sale register recording prescriber name/address, patient name, drug name, quantity; records kept for 3 years, open to inspection [3].
• Schedule X: narcotic/psychotropic drugs with the strictest sale/storage/record norms, sold only on RMP prescription [5].
• Draft notification date: 8 September 2026 [1].
• New proposed safeguard: CCTV surveillance at retail medical stores [1].

5. Multi-Dimensional Analysis

Social

• Aims to prevent drug misuse/self-medication, particularly of habit-forming and antibiotic drugs, protecting public health [1][3].

Legal/Constitutional

• Amendment exercised via rule-making power under the Drugs and Cosmetics Act, 1940 (subordinate legislation, not fresh statute) [2].
• Continues precedent of using Schedule reclassification (2013, 2015, July 2026) as the regulatory tool [3][4].

Administrative/Governance

• Enforcement burden falls on state drug control authorities and retail pharmacies (CCTV compliance, register maintenance) — a federal implementation challenge [1][3].
• Enhances traceability and accountability across the pharma retail supply chain [1].

Scientific/Public Health

• Directly linked to India's fight against Antimicrobial Resistance (AMR), since Schedule H1 covers critical antibiotics [3].

Economic

• Compliance costs (CCTV installation, record-keeping) for small/rural pharmacies could be a friction point.

6. Recent Developments (last 12-18 months)

• July 2026: High-alcohol-content drug formulations (>12% v/v ethanol, >30 mL) shifted from Schedule K exemption to Schedule H1 [4].
• 8 September 2026: Draft notification proposing amendments to Drugs Rules, 1945 for Schedule H, H1, X oversight, including CCTV surveillance proposal [1].

7. Prelims Hooks

• Drugs Rules, 1945 are framed under the Drugs and Cosmetics Act, 1940 [2].
• Schedule H1 was introduced via GSR 588(E) dated 30 August 2013, effective 1 March 2014 [3].
• Schedule H1 originally listed 46 drugs [3].
• Schedule H1 sale records must be maintained for 3 years [3].
• Schedule X covers narcotic and psychotropic substances [5].
• 2015 amendment banned advertisement of Schedule H, H1, X drugs without Central Government sanction [4].
• July 2026: alcohol threshold for Schedule K exemption removal set at 12% v/v and 30 mL [4].
• Draft amendment proposing CCTV at medical stores dated 8 September 2026 [1].
• Regulatory body for drug standards in India: CDSCO, under MoHFW.
• Schedule H and X drugs require sale only on RMP prescription [3][5].

8. The Register Rule Already Exists — And Chemists Already Skip It

• The new draft adds cameras to a rule that is old and weakly followed
• Schedule H1 has required a separate sale register since 1 March 2014 — prescriber name, patient name, drug, quantity, kept 3 years [3].
• Antibiotics are still handed over the counter in India without a prescription. Unregulated retail sale is listed as a main driver of India's antimicrobial resistance (AMR) burden — AMR means germs stop responding to medicines [7].

• So the gap is not that the rule is missing. The gap is that nobody checks the register.

• The reason nobody checks is old and documented

• The Mashelkar Committee (2003) found three faults in India's drug regulatory system: too few trained staff at central and state level, no uniformity in how rules are enforced across states, and weak drug control infrastructure [6].
• PRS notes that the Drugs and Cosmetics (Amendment) Bills of 2005 and 2007 did not act on the recommendations for strengthening drug regulation at the state level [6].
• Drug licensing and inspection of chemist shops is done by state drug controllers, not by CDSCO. A central gazette notification cannot create a state inspector [1][6].

9. Who Will Actually Watch the CCTV Footage?

• A camera only records. It does not catch anyone
• Footage becomes useful only if a drug inspector visits, asks for it, and matches it against the Schedule H1 register [1][3].
• That is exactly the inspection capacity Mashelkar (2003) said India does not have [6].

• Result risk: the shop installs a camera, ticks the compliance box, and sells the same way.

• Three things the draft must settle before it is notified

• How long footage is kept. Schedule H1 registers have a clear 3-year rule [3]. A camera rule with no matching retention period gives an inspector nothing to look back at.
• Who can view it. A chemist's counter records sick people buying anti-TB drugs and psychiatric medicines. That is sensitive health information about identifiable patients.
• Who pays. The cost of the camera, storage and electricity falls on the single-counter rural chemist, not on the large urban chain. A uniform rule hits the small shop hardest.

10. The Strongest Case Against This — and Why It Only Half Works

• The objection, put at its strongest
• In much of rural India the chemist is the first person a sick family meets, and sometimes the only one. Getting a Registered Medical Practitioner's (RMP) prescription may mean a day's travel and a day's lost wages.
• Tighten the counter without adding prescribers, and you do not stop the medicine — you push the buyer to a quack, to a leftover strip at home, or to a half course. A half course of antibiotics breeds resistance faster than a full one.

• The honest part of this objection: India's own regulatory record shows rules are added faster than enforcement capacity is built [6].

• Why it still does not defeat the amendment

• The rule does not ban the drug. It requires a prescription that can be written by any RMP, including at a PHC.
• Schedule H1 deliberately covers a narrow list — 46 drugs, mainly third and fourth generation antibiotics, anti-TB drugs and habit-forming drugs [3]. Ordinary first-line medicine stays reachable.
• The correct answer to the objection is sequencing, not dropping the rule: link enforcement dates to prescriber availability in that district, and give chemists a legal route (a pharmacist-led refill or teleconsultation prescription) so the lawful path is also the easy path.

11. What This Rule Cannot Touch: The Doctor's Pen and the Animal Shed

• This is a sale-side rule only
• Drugs Rules, 1945 control the chemist's counter — licence, prescription, register, and now cameras [1][2].
• But overprescription by doctors is also a main driver of AMR in India [7]. A perfect register cannot stop a doctor writing a third-generation antibiotic for a common cold; that prescription is fully legal.

• Prescribing behaviour is governed by the National Medical Commission, not by these Rules. So the amendment fixes one half of a two-half problem.

• Misuse in animal husbandry sits outside these Rules too

• Antibiotic misuse in animals is listed among the drivers of resistance in India [7]. Resistant germs do not stay on the farm.

• For Mains, this is the sharp line: drug scheduling is a retail-access tool. AMR is a One Health problem covering humans, animals and the environment. Scheduling alone cannot carry it.

• India is moving with the global current, not against it

• WHO runs a global campaign to phase out over-the-counter sale of antibiotics [8]. So the direction of the September 2026 draft is internationally backed; the doubt is only about enforcement, not about intent.

12. Anchors for Answers

• Data: Schedule H1 covers 46 specified drugs; sale register must be kept for 3 years and is open to inspection [3]
• Report/Committee: Mashelkar Committee, 2003 — too few trained regulatory staff, no uniformity in enforcement across states, weak state drug control infrastructure [6]
• Law/Case: Drugs and Cosmetics Act, 1940 (parent Act) read with Drugs Rules, 1945; draft amendment notified 8 September 2026 [1][2]; Schedule X overlaps with the NDPS Act, 1985
• Comparison: WHO's global campaign to phase out over-the-counter sale of antibiotics — India's Schedule H1 route fits this worldwide push [8]
• Scheme: Red Line Campaign (red vertical line on antibiotic packs) and the National Action Plan on AMR — the awareness and One Health arms that a sale-counter rule cannot replace

13. Mains Relevance

• GS-II: Government policies and interventions for development in the health sector; issues relating to health governance.
• GS-III: Science and technology issues concerning public health; challenges of Antimicrobial Resistance (AMR).
• Possible question stems:
• Discuss the significance of Schedule H, H1 and X under the Drugs Rules, 1945 in regulating access to prescription and habit-forming drugs in India.
• Antimicrobial resistance is a silent pandemic. Examine how India's drug scheduling regime addresses this challenge.
• Critically evaluate the administrative challenges in enforcing pharmaceutical retail regulations across India's federal structure.

14. Related Topics to Study Next

• Antimicrobial Resistance (AMR) & National Action Plan on AMR — directly linked to Schedule H1 rationale [3].
• Drugs and Cosmetics Act, 1940 — parent legislation.
• CDSCO and drug regulatory architecture in India — implementing body.
• Narcotic Drugs and Psychotropic Substances (NDPS) Act, 1985 — overlaps with Schedule X drugs.
• New Drugs and Clinical Trials Rules, 2019 — related regulatory framework for trials.
• National Pharmaceutical Pricing Authority (NPPA) — pricing regulation complementing sale regulation.
• National Medical Commission Act, 2019 — regulates RMPs who prescribe scheduled drugs.

15. Common Errors / Trap Areas

• Confusing Schedule H (general prescription drugs) with Schedule H1 (specific list of antibiotics/habit-forming drugs with register requirement) — they have different compliance obligations [3].
• Assuming Schedule X drugs fall under the Drugs Rules alone — they overlap with NDPS Act controls too.
• Misattributing the amending authority to CDSCO instead of the Union Health Ministry (MoHFW), which issues the gazette notification [1].
• Confusing the 2026 CCTV/oversight proposal with the 2013 introduction of Schedule H1 — these are distinct, chronologically separate amendments [1][3].